How long should patients be followed after molar pregnancy? Analysis of serum hCG follow-up data

被引:26
作者
Batorfi, J [1 ]
Vegh, G [1 ]
Szepesi, J [1 ]
Szigetvari, I [1 ]
Doszpod, J [1 ]
Fulop, V [1 ]
机构
[1] Natl Hlth Ctr, Dept Obstet & Gynecol, H-1135 Budapest, Hungary
关键词
gestational trophoblastic disease; complete and partial hydatidiform mole; human chorionic gonadotropin; hCG; follow up;
D O I
10.1016/S0301-2115(03)00274-4
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: We analyzed human chorionic gonadotropin (hCG) follow-up data of patients with molar pregnancy. Women often do not complete recommended post-disease screening. Our purpose was to determine if continuing follow up of uncomplicated molar cases beyond attaining undetectable hCG levels is necessary for detecting relapse of gestational trophoblastic disease. Study design: One hundred fifty patients treated at Hungarian National Health Center were analyzed. Those who developed persistent disease before hCG had become undetectable were excluded from further analysis (n = 24; 16%). Results: Among 126 uncomplicated cases, 72 patients (57%) completed follow up, and 54 (43%) discontinued their protocol before it had been completed. Of 120 patients who achieved at least one undetectable hCG level, none had any evidence of relapse. Conclusion: In uncomplicated hydatidiform mole, our analysis indicates that once undetectable serum hCG levels are attained, relapse is unlikely. Although further monthly checks are advisable, the likelihood of recurrence appears very low. (C) 2003 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:95 / 97
页数:3
相关论文
共 15 条
  • [1] Medical progress - Chorionic tumors
    Berkowitz, RS
    Goldstein, DP
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (23) : 1740 - 1748
  • [2] ANALYSIS OF 309 CASES AFTER HYDATIDIFORM MOLE - DIFFERENT FOLLOW-UP PROGRAM ACCORDING TO BIOLOGIC BEHAVIOR
    BOLIS, G
    BELLONI, C
    BONAZZI, C
    MANGILI, G
    PRESTI, M
    ZANABONI, F
    MANGIONI, C
    [J]. TUMORI JOURNAL, 1988, 74 (01): : 93 - 96
  • [3] Human chorionic gonadotropin follow-up in patients with molar pregnancy: A time for reevaluation
    Feltmate, CM
    Batorfi, J
    Fulop, V
    Goldstein, DP
    Doszpod, J
    Berkowitz, RS
    [J]. OBSTETRICS AND GYNECOLOGY, 2003, 101 (04) : 732 - 736
  • [4] Garner EIO, 2002, J REPROD MED, V47, P380
  • [5] EFFECTS OF PROPHYLACTIC CHEMOTHERAPY FOR PERSISTENT TROPHOBLASTIC DISEASE IN PATIENTS WITH COMPLETE HYDATIDIFORM MOLE
    KIM, DS
    MOON, H
    KIM, KT
    MOON, YJ
    HWANG, YY
    [J]. OBSTETRICS AND GYNECOLOGY, 1986, 67 (05) : 690 - 694
  • [6] KOHORN EI, 1982, OBSTET GYNECOL, V59, P78
  • [7] NATURAL-HISTORY OF HYDATIDIFORM MOLE AFTER PRIMARY EVACUATION
    LURAIN, JR
    BREWER, JI
    TOROK, EE
    HALPERN, B
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1983, 145 (05) : 591 - 595
  • [8] Poor compliance with postmolar surveillance and treatment protocols by indigent women
    Massad, LS
    Abu-Rustum, NR
    Lee, SS
    Renta, V
    [J]. OBSTETRICS AND GYNECOLOGY, 2000, 96 (06) : 940 - 944
  • [9] Hydatidiform mole: Clinical analysis of 310 patients
    Mungan, T
    Kuscu, E
    Dabakoglu, T
    Senoz, S
    Ugur, M
    Cobanoglu, O
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1996, 52 (03) : 233 - 236
  • [10] A clinical, histopathological and flow cytometric study of 149 complete moles, 146 partial moles and 107 non-molar hydropic abortions
    Paradinas, FJ
    Browne, P
    Fisher, RA
    Foskett, M
    Bagshawe, KD
    Newlands, E
    [J]. HISTOPATHOLOGY, 1996, 28 (02) : 101 - 109